Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
NCT01177280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2012-05-01
Summary
This study explored the prevalence of DDEs in a chronic pain population with cLBP and associated healthcare utilization and costs using a healthcare claims database.
Conditions
- Chronic Low Back Pain
Sponsors & Collaborators
-
NEMA Research, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2010-12-31
- Completion
- 2011-01-31
More Related Trials
-
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
NCT00763321 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Pain Relief in Low Back Pain
NCT00325949 ·Status: COMPLETED ·Phase: PHASE3
-
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
NCT01240863 ·Status: COMPLETED ·Phase: PHASE3
-
Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)
NCT01685684 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
NCT01081912 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
NCT00771758 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain
NCT00195728 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety of PF-00345439 (Oxycodone)
NCT01559701 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution of Analgesic Tolerance With Opioids
NCT00275249 ·Status: COMPLETED ·Phase: NA
-
The Oxford Pain, Activity and Lifestyle (OPAL) Cohort Study
NCT02820571 ·Status: UNKNOWN
-
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
NCT01922739 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
NCT00361504 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid Taper Study
NCT03912298 ·Status: COMPLETED
-
HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain
NCT06931158 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment
NCT01319279 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
NCT01677065 ·Status: COMPLETED
-
A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis
NCT00784810 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
NCT01530542 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time
NCT01223365 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
NCT02259179 ·Status: COMPLETED ·Phase: PHASE1
-
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
NCT00986180 ·Status: COMPLETED ·Phase: PHASE3